Medicine & Life Sciences
Serbia
100%
Ulcerative Colitis
72%
Crohn Disease
70%
Inflammatory Bowel Diseases
69%
Health Care Costs
65%
Costs and Cost Analysis
45%
Health Expenditures
21%
Developed Countries
20%
Biosimilar Pharmaceuticals
14%
Cost of Illness
12%
Biological Therapy
12%
Biological Products
10%
Health Services
9%
Economics
8%
Hospitalization
7%
Business & Economics
Serbia
82%
Costs
27%
Median
17%
Cost of Illness
13%
Developed Countries
12%
Resources
11%
Hospitalization
11%
Indirect Costs
11%
Economic Transition
11%
Illness
10%
Health Services
9%
Questionnaire
8%
Therapy
7%
Socioeconomic
7%
Expenditure
6%
Patient with Inflammatory Bowel Disease
4%
Patient with Ulcerative Colitis
1%
Patient with Crohn's Disease
1%
Social Sciences
Serbia
82%
costs
41%
illness
11%
utilization
11%
transition economics
9%
hospitalization
8%
Euro
7%
republic
6%
expenditures
6%
resources
6%
health service
5%
history
3%
questionnaire
3%
Group
2%